The role of cytokeratin 19 in the differential diagnosis of true papillary carcinoma of thyroid and papillary carcinoma-like changes in Graves' disease

被引:27
作者
Erkilic, Suna [1 ]
Kocer, N. Emrah [1 ]
机构
[1] Gaziantep Univ, Fac Med, Dept Pathol, Gaziantep, Turkey
关键词
thyroid; cytokeratin; 19; Graves' disease; papillary carcinoma;
D O I
10.1385/EP:16:1:063
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Graves' disease is an autoimmune disease predominantly seen in females. All types of thyroid cancers may co-exist with Graves' disease but papillary carcinoma is the most frequent. Vesicular nuclei, nuclear grooves, and papillary formations that may be seen in Graves' disease may lead the pathologist to an overdiagnosis of papillary carcinoma. The differential diagnosis between a true papillary carcinoma and foci mimicking papillary carcinoma in Graves' disease may be challenging by light microscopic features only. This study is designed to determine whether CK19 is effective in the discrimination between the true papillary carcinoma of thyroid and foci resembling papillary carcinoma in Graves' disease. Twenty-five cases with papillary carcinoma and 25 cases with Graves' disease containing foci resembling papillary carcinoma were included in the study. All 25 cases with papillary carcinoma stained positive with CK19, whereas only six of 25 cases with Graves' disease showed weak staining, and the remaining 19 cases were completely negative. It is known that CK19 may show faint staining in benign thyroid lesions such as adenomas. Staining pattern with CK19 together with histopathological findings may be helpful in the differential diagnosis between foci mimicking papillary carcinoma and true papillary carcinoma in Graves' disease.
引用
收藏
页码:63 / 66
页数:4
相关论文
共 14 条
[1]   Differential expression of cytokeratins in follicular variant of papillary carcinoma: An immunohistochemical study and its diagnostic utility [J].
Baloch, ZW ;
Abraham, S ;
Roberts, S ;
LiVolsi, VA .
HUMAN PATHOLOGY, 1999, 30 (10) :1166-1171
[2]  
BENNETT WP, 1988, LAB INVEST, V58, pA9
[3]   Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1 [J].
Casey, MB ;
Lohse, CM ;
Lloyd, RV .
ENDOCRINE PATHOLOGY, 2003, 14 (01) :55-60
[4]  
Daou R, 1998, Chirurgie, V123, P604, DOI 10.1016/S0001-4001(99)80011-7
[5]   Diagnostic utility of cytokeratin 19 expression in multinodular goiter with papillary areas and papillary carcinoma of thyroid [J].
Erkilic, S ;
Aydin, A ;
Koçer, NE .
ENDOCRINE PATHOLOGY, 2002, 13 (03) :207-211
[6]   Thyroid cancer in patients with hyperthyroidism [J].
Gabriele, R ;
Letizia, C ;
Borghese, M ;
De Toma, G ;
Celi, M ;
Izzo, L ;
Cavallaro, A .
HORMONE RESEARCH, 2003, 60 (02) :79-83
[7]   Utility of immunohistochemistry in the evaluation of necrotic thyroid tumors [J].
Judkins, AR ;
Roberts, SA ;
Livolsi, VA .
HUMAN PATHOLOGY, 1999, 30 (11) :1373-1376
[8]   Distribution of keratins in normal endothelial cells and a spectrum of vascular tumors: Implications in tumor diagnosis [J].
Miettinen, M ;
Fetsch, JF .
HUMAN PATHOLOGY, 2000, 31 (09) :1062-1067
[9]   Variable expression of keratins and nearly uniform lack of thyroid transcription factor 1 in thyroid anaplastic carcinoma [J].
Miettinen, M ;
Franssila, KO .
HUMAN PATHOLOGY, 2000, 31 (09) :1139-1145
[10]  
Rosai J, 2004, SURG PATHOLOGY, V1, P515